ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,258Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 623

$896K Total Retail Price of All Prescriptions

Rank: 6 out of 623

378 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 378 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 378 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 10,579 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 464 370 1 4
SIMVASTATIN 438 344 2 2
OMEPRAZOLE 386 291 3 7
FUROSEMIDE 382 321 4 5
JANTOVEN 363 314 5 54
POTASSIUM CHLORIDE 351 290 6 24
AMLODIPINE BESYLATE 342 264 7 3
LISINOPRIL 338 242 8 1
METFORMIN HCL 252 163 9 6
METOPROLOL TARTRATE 240 212 10 9
TRAMADOL HCL 216 156 11 15
DONEPEZIL HCL 213 213 12 27
METOPROLOL SUCCINATE 211 112 13 13
MIRTAZAPINE 208 192 14 31
CITALOPRAM HBR 201 164 15 21
GABAPENTIN 185 105 16 18
TRAZODONE HCL 178 145 17 36
ATORVASTATIN CALCIUM 172 146 18 10
LANTUS 169 138 19 41
WARFARIN SODIUM 167 123 20 14
OLANZAPINE 159 128 21 120
CLONIDINE HCL 157 125 22 55
NOVOLOG 146 118 23 75
SERTRALINE HCL 139 101 24 20
ALBUTEROL SULFATE 134 83 25 69
TAMSULOSIN HCL 125 107 26 35
HYDROCHLOROTHIAZIDE 120 85 27 8
POLYETHYLENE GLYCOL 3350 118 84 28 53
PREDNISONE 118 62 28 40
PRAVASTATIN SODIUM 112 69 30 11
ZOLPIDEM TARTRATE 109 53 31 22
RISPERIDONE 109 93 31 49
NYSTATIN 104 80 33 141
LIDODERM 104 89 33 82
CYMBALTA 101 69 35 52
NAMENDA 97 95 36 47
FLUTICASONE PROPIONATE 94 53 37 29
IPRATROPIUM BROMIDE 94 74 37 133
RANITIDINE HCL 94 66 37 23
QUETIAPINE FUMARATE 92 68 40 51
CARBIDOPA-LEVODOPA 92 92 40 88
ISOSORBIDE MONONITRATE ER 91 79 42 64
PROMETHAZINE HCL 89 59 R 43 139
EXELON 87 83 44 125
SODIUM CHLORIDE 85 53 45 167
FLUOXETINE HCL 84 50 46 84
FAMOTIDINE 82 59 47 112
ESCITALOPRAM OXALATE 80 73 48 60
PAROXETINE HCL 78 74 49 66
AMOX TR-POTASSIUM CLAVULANATE 72 56 50 132
CIPROFLOXACIN HCL 72 60 50 61
HEPARIN SODIUM 71 53 52 179
CLOPIDOGREL 68 55 53 34
LOVASTATIN 66 64 54 25
CARVEDILOL 64 52 55 32
LEVOFLOXACIN 64 51 55 72
ADVAIR DISKUS 64 46 55 39
LYRICA 62 39 58 86
OXYBUTYNIN CHLORIDE 60 46 59 134
BACLOFEN 60 12 59 115
PANTOPRAZOLE SODIUM 59 48 61 26
ENOXAPARIN SODIUM 59 54 61 162
LOSARTAN POTASSIUM 59 42 61 16
INSULIN SYRINGE 58 21 64 80
KLOR-CON M20 57 45 65 62
LOPERAMIDE 56 35 66 215
CEPHALEXIN 55 43 67 102
SPIRIVA 55 36 67 58
OXYCODONE-ACETAMINOPHEN 53 26 S2 69 42
IPRATROPIUM-ALBUTEROL 53 44 69 91
SINGULAIR 53 39 69 109
KLOR-CON 10 52 51 72 119
DIOVAN 51 51 73 48
DIVALPROEX SODIUM 51 51 73 77
ONDANSETRON HCL 50 31 75 287
PLAVIX 50 41 75 46
FINASTERIDE 50 50 75 107
LEVETIRACETAM 50 23 75 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.